PRMT7 and breast carcinoma: We initially thoroughly validated a PRMT7 polyclonal antibody for use in this study and have shown that it specifically detects PRMT7 in Western blots of breast cancer cell lines with no other non-specific activity (Supplementary Figure 1A).